Home Nav
Nextech Invest Logo
Nextech Invest

Nextech Invest relies on a stringent process to select portfolio companies. This process begins by connecting to companies through a global network of key opinion leaders, scientific experts, business partners, and academic sources. Next, a comprehensive assessment of the target company is carried out by the Nextech investment team in conjunction with our Scientific Board to determine whether the company meets out investment criteria. 

To date, we have assessed over 1000 cancer companies world-wide covering more than 100 oncology indications. Since 2007 we have invested in 16 exceptional companies.

Traditional cancer treatments

Traditional treatments include chemotherapy, radiation, and surgery with the objective to eradicate cancer cells while sparing healthy cells. Most current therapies come with undesirable side effects and often lack significant efficacy. With ongoing research, treatments are becoming increasingly effective and safe.

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close